Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Apr 30;10(4):e0127133. doi: 10.1371/journal.pone.0127133. eCollection 2015. No abstract available.

2.

Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Mar 27;10(3):e0122209. doi: 10.1371/journal.pone.0122209. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127133. Aspita, Alvaro Moreno [corrected to Moreno-Aspitia, Alvaro].

3.

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Borges S, Döppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson E, Geiger XJ, Storz P.

Breast Cancer Res. 2013 Aug 23;15(2):R66. doi: 10.1186/bcr3460.

4.

Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Barten DM, Fanara P, Andorfer C, Hoque N, Wong PY, Husted KH, Cadelina GW, Decarr LB, Yang L, Liu V, Fessler C, Protassio J, Riff T, Turner H, Janus CG, Sankaranarayanan S, Polson C, Meredith JE, Gray G, Hanna A, Olson RE, Kim SH, Vite GD, Lee FY, Albright CF.

J Neurosci. 2012 May 23;32(21):7137-45. doi: 10.1523/JNEUROSCI.0188-12.2012.

5.

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.

Strizzi L, Hardy KM, Margaryan NV, Hillman DW, Seftor EA, Chen B, Geiger XJ, Thompson EA, Lingle WL, Andorfer CA, Perez EA, Hendrix MJ.

Breast Cancer Res. 2012 May 11;14(3):R75.

6.

MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.

Andorfer CA, Necela BM, Thompson EA, Perez EA.

Trends Mol Med. 2011 Jun;17(6):313-9. doi: 10.1016/j.molmed.2011.01.006. Epub 2011 Mar 2. Review.

PMID:
21376668
7.

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

Perez EA, Jenkins RB, Dueck AC, Wiktor AE, Bedroske PP, Anderson SK, Ketterling RP, Sukov WR, Kanehira K, Chen B, Geiger XJ, Andorfer CA, McCullough AE, Davidson NE, Martino S, Sledge GW, Kaufman PA, Kutteh LA, Gralow JR, Harris LN, Ingle JN, Lingle WL, Reinholz MM.

J Clin Oncol. 2011 Feb 20;29(6):651-9. doi: 10.1200/JCO.2010.30.2125. Epub 2011 Jan 18.

8.

Adjuvant therapy of triple negative breast cancer.

Perez EA, Moreno-Aspitia A, Aubrey Thompson E, Andorfer CA.

Breast Cancer Res Treat. 2010 Apr;120(2):285-91. doi: 10.1007/s10549-010-0736-z. Epub 2010 Jan 22. Review.

9.

A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease.

Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW, Farrer MJ.

Neuroscience. 2007 Jul 29;147(4):1047-58. Epub 2007 Jul 3.

PMID:
17611037
10.

Accumulation of pathological tau species and memory loss in a conditional model of tauopathy.

Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C.

J Neurosci. 2007 Apr 4;27(14):3650-62.

11.

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P.

J Neurosci. 2005 Jun 1;25(22):5446-54.

12.

Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SH.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3022-7. Epub 2005 Feb 7.

13.

Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.

Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P.

J Neurochem. 2003 Aug;86(3):582-90.

14.
15.

PKA phosphorylations on tau: developmental studies in the mouse.

Andorfer CA, Davies P.

Dev Neurosci. 2000;22(4):303-9.

PMID:
10965152
16.

Effects of nitrogen limitation on biofilm formation in a hydrocarbon-degrading trickle-bed filter.

Holubar P, Andorfer C, Braun R.

Appl Microbiol Biotechnol. 1999 Apr;51(4):536-40.

PMID:
10341437
17.

Enhancement of insect antifreeze protein activity by solutes of low molecular mass.

Li N, Andorfer CA, Duman JG.

J Exp Biol. 1998 Aug;201(Pt 15):2243-51.

18.

Molecular characterization and sequencing of antifreeze proteins from larvae of the beetle Dendroides canadensis.

Duman JG, Li N, Verleye D, Goetz FW, Wu DW, Andorfer CA, Benjamin T, Parmelee DC.

J Comp Physiol B. 1998 Apr;168(3):225-32.

PMID:
9591363

Supplemental Content

Loading ...
Support Center